Skip to content
★ Sign in to follow
DW

D Waterhouse

CEO
Total declarations
13
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 20 Jul 2023 for GSK plc, €10k.

Filing timeline

BuySale
D Waterhouse

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

  • GSK plc 4 purchases · last 20 Jul 2023

D Waterhouse: trading record in brief

This profile gathers the share dealings of D Waterhouse in GSK plc. In total, 13 filings cover trades dated from 9 August 2022 to 18 July 2023.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 20 July 2023: a share grant of €10k, in GSK plc. Typically, a trade is published a median of 2 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Companies and markets linked to D Waterhouse

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    CEO, ViiV Healthcare and President, Global Health, GSKExecutivesGSK plc
    8,951 GBP30RNS
    673 shares@ £13.3087.5% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-10
  • ▲
    CEO, ViiV HealthcareExecutivesGSK plc
    0RNS
    0London Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-23
    Canonical exit: 16 Oct 2023 (T+90)
  • ▲
    CEO, ViiV HealthcareExecutivesGSK plc
    761 GBP41RNS
    57 shares@ £13.35327.5% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-9
    Canonical exit: 11 Oct 2023 (T+90)
  • ▲
    CEO, ViiV Healthcare and President, Global Health, GSKExecutivesGSK plc
    261 GBP40RNS
    20 shares@ £13.0672.6% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4835002-7
    Canonical exit: 9 Oct 2023 (T+90)
  • ▲
    CEO, ViiV Healthcare and President, Global Health, GSKExecutivesGSK plc
    248 GBP40RNS
    18 shares@ £13.79672.4% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4799763-7
    Canonical exit: 7 Sept 2023 (T+90)

5 of 5 declarations